drugs
CT Mirror Viewpoint: Husky MCOs would harm access to mental health care
A new CT Mirror Viewpoint from a HUSKY mental health provider describes why the Governor’s idea to bring managed care back would drive more providers from the program. Demand for mental health care has never been higher and is a serious concern for HUSKY. Donna Nicolino is a trauma specialist participating in both Connecticut’s non-MCO…
Read MoreBook Club: Risky Business—Why Insurance Markets Fail And What to Do About It
I thought I knew a lot about how insurance markets work (and don’t), but I learned more than I expected from Risky Business—Why Insurance Markets Fail And What to Do About It by Liran Einav, Amy Finkelstein, and Ray Fishman. Adverse selection (commonly called cherry picking) is a double-edged problem. I knew about insurers’ schemes…
Read MoreWebinar offers tools to improve prescribing
Download the slides and watch the webinar recording Connecticut, like other states, are struggling to improve appropriate prescribing while lowering costs. In Friday’s webinar, Greg Low, RPh, PhD, offered Mass General’s experience of what works to improve physician prescribing at their ACO. Greg is the Manager for Pharmacy Operations at Mass General Brigham Health Plan.…
Read MoreAnalysis: Governor’s healthcare budget is a mixed bag
In his new budget proposal, Gov. Ned Lamont and his administration have continued their commitment to making healthcare in Connecticut more affordable. They understand healthcare’s large and growing burden on state residents, employers, and taxpayers. They also understand the challenges, given Connecticut’s historically poor record on reforms. Some proposals make sense, and some are more…
Read MoreWebinar: Improved prescribing through education and reporting
Connecticut providers and payers are struggling to find ways to address prescription costs and the quality of prescribing. Hear how Mass General Hospital & Physicians Organization’s program improved prescribing quality and efficiency. The webinar is Friday, February 16th at 1pm. Register here. Greg Low, RPh, PhD recently transitioned to a new position as the Manager…
Read MoreCT again among healthiest states overall, but with big areas of concern
Connecticut ranked 4th healthiest among states in this year’s America’s Health Ranking, from the United Health Foundation. We were the best state in climate policies, childhood immunizations, and adult dental visits. But we were in the bottom on other indicators. Connecticut is in a very healthy region of the US, with New Hampshire (#1), Massachusetts…
Read MoreNo evidence to justify price increases for eight of top 10 most costly drugs
ICER’s latest Unsupported Price Increase report from the Institute for Clinical and Economic Review finds that, last year, eight of the ten most costly drugs in the US that raised net prices well over the rate of general inflation, had no new clinical evidence of effectiveness to justify the increases. The increases on just these…
Read MoreAnalysis: Medicare is Negotiating Drug Prices — Why it Matters
This is historic. Pharma has been fighting Medicare drug price negotiation for decades because it’s the start of reining in their extreme prices. But it’s just a start. Don’t start spending your savings yet. Read more
Read MoreICER seeking nominations for New England evidence review council
The Institute for Economic and Clinical Review (ICER) is seeking nominations for new members to the New England Comparative Effectiveness Public Advisory Council (New England CEPAC). In my time on the New England CEPAC, it was an exciting dive into learning new things with a team of exceptional experts and colleagues from across the region.…
Read MoreICER fair access report finds improvements but problems with transparency
ICER’s third annual Barriers to Fair Access report found that most prescription drug coverage policies met fair rules for patient access. This is an improvement over previous years suggesting that transparency and public sunlight works. But the report also found that policies needed more transparency and are too complex. Policies on which patients are eligible…
Read More